{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:52:58Z","timestamp":1777006378265,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.spen.2015.10.003","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T23:05:13Z","timestamp":1445727913000},"page":"274-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Natural History and Current Treatment Options for Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex"],"prefix":"10.1016","volume":"22","author":[{"given":"Sergiusz","family":"J\u00f3\u017awiak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Mandera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"M\u0142ynarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2015.10.003_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-4632.2010.04727.x","article-title":"Tuberous sclerosis complex tumors and tumorigenesis","volume":"50","author":"Borkowska","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.spen.2015.10.003_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2015.10.003_bib3","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/jnen\/63.12.1236","article-title":"Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: Biallelic inactivation of TSC1 or TSC2 leads to mTOR activation","volume":"63","author":"Chan","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.spen.2015.10.003_bib4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: Recommendations of the 2012 international tuberous sclerosis complex consensus conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2015.10.003_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1528-1167.2010.02892.x","article-title":"Cerebral tuber count and its impact on mental outcome of patients with tuberous sclerosis complex","volume":"52","author":"Kaczorowska","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.spen.2015.10.003_bib6","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","article-title":"Causes of death in patients with tuberous sclerosis","volume":"66","author":"Shepherd","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.spen.2015.10.003_bib7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pediatrneurol.2014.11.013","article-title":"Tuberous sclerosis complex: A survey on health care resource use and health burden","volume":"52","author":"Rentz","year":"2015","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2015.10.003_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00381-014-2555-8","article-title":"Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex","volume":"30","author":"Kotulska","year":"2014","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.spen.2015.10.003_bib9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-1331.2009.02567.x","article-title":"Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature","volume":"16","author":"Adriaensen","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.spen.2015.10.003_bib10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2 compared with TSC1 disease in multiple organs","volume":"68","author":"Dabora","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2015.10.003_bib11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00381-002-0700-2","article-title":"Subependymal giant cell astrocytoma in children with tuberous sclerosis","volume":"19","author":"Cuccia","year":"2003","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.spen.2015.10.003_bib12","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/jnnp.66.3.370","article-title":"Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis","volume":"66","author":"Nabbout","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.spen.2015.10.003_bib13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pediatrneurol.2013.08.017","article-title":"Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the international tuberous sclerosis complex consensus conference","volume":"49","author":"Roth","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2015.10.003_bib14","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/ejhg.2015.47","article-title":"Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2","volume":"23","author":"Kwiatkowski","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.spen.2015.10.003_bib15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejpn.2012.12.008","article-title":"Participants of the TSC Consensus Meeting for SEGA and Epilepsy Management. Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations","volume":"17","author":"J\u00f3\u017awiak","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.spen.2015.10.003_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12519-010-0025-2","article-title":"Management of subependymal giant cell tumors in tuberous sclerosis complex: The neurosurgeon\u2019s perspective","volume":"6","author":"Berhouma","year":"2010","journal-title":"World J Pediatr"},{"key":"10.1016\/j.spen.2015.10.003_bib17","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/088307380001501003","article-title":"Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients","volume":"15","author":"J\u00f3\u017awiak","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2015.10.003_bib18","first-page":"39","article-title":"Subependymal giant cell astrocytomas with atypical histological features mimicking malignant gliomas","volume":"49","author":"Grajkowska","year":"2011","journal-title":"Folia Neuropathol"},{"key":"10.1016\/j.spen.2015.10.003_bib19","first-page":"1321","article-title":"Immunohistochemical and microscopic studies on giant cells in tuberous sclerosis","volume":"20","author":"J\u00f3\u017awiak","year":"2005","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.spen.2015.10.003_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.pediatrneurol.2013.12.004","article-title":"Surgical treatment of subependymal giant-cell astrocytoma in tuberous sclerosis complex patients","volume":"50","author":"Kotulska","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2015.10.003_bib21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF00301665","article-title":"Surgical treatment of intraventricular tumors associated with tuberous sclerosis","volume":"11","author":"Roszkowski","year":"1995","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.spen.2015.10.003_bib22","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1212\/01.WNL.0000142039.14522.1A","article-title":"Subependymal giant cell tumours in tuberous sclerosis complex","volume":"63","author":"Goh","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2015.10.003_bib23","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00381-011-1406-0","article-title":"The management of subependymal giant cell tumors in tuberous sclerosis: A clinician\u2019s perspective","volume":"27","author":"Moavero","year":"2011","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.spen.2015.10.003_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/088307389801300405","article-title":"Early diagnosis of subependymal giant cell astrocytoma in patients with tuberous sclerosis","volume":"13","author":"Torres","year":"1998","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2015.10.003_bib25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: Recommendations of the 2012 international tuberous sclerosis complex consensus conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2015.10.003_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejpn.2011.09.006","article-title":"Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex","volume":"16","author":"Perek-Polnik","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.spen.2015.10.003_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/03007995.2012.658907","article-title":"Outcomes of resectings ubependymal giant cell astrocytoma (SEGA) among patients with SEGA-related tuberous sclerosis complex: A national claimsdatabaseanalysis","volume":"28","author":"Sun","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.spen.2015.10.003_bib28","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2217\/fon.12.146","article-title":"Everolimus (RAD001): first systemic treatment for subependymal giant cell astrocytoma associated with tuberous sclerosis complex","volume":"8","author":"J\u00f3zwiak","year":"2012","journal-title":"Future Oncol"},{"key":"10.1016\/j.spen.2015.10.003_bib29","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2015.10.003_bib30","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.spen.2015.10.003_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Phase 3 trial of everolimus in subependymal giant cell astrocytomas associated with tuberous sclerosis complex","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2015.10.003_bib32","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S1470-2045(14)70489-9","article-title":"Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-Year open-label extension of the randomised EXIST-1 study","volume":"15","author":"Franz","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.spen.2015.10.003_bib33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/pbc.25368","article-title":"Factors affecting response to everolimus therapy for subependymal giant cell astrocytomas associated with tuberous sclerosis","volume":"62","author":"Trelinska","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.spen.2015.10.003_bib34","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00381-013-2170-0","article-title":"Successful everolimus therapy for SEGA in pediatric patients with tuberous sclerosis complex","volume":"29","author":"Cappellano","year":"2013","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.spen.2015.10.003_bib35","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejpn.2013.03.002","article-title":"Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex","volume":"17","author":"Kotulska","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.spen.2015.10.003_bib36","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1542\/peds.2012-3607","article-title":"Possible prevention of tuberous sclerosis complex lesions","volume":"132","author":"Kotulska","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.spen.2015.10.003_bib37","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/CAD.0000000000000207","article-title":"Complications of mammalian target of rapamycin inhibitor anticancer treatment among patients with tuberous sclerosis complex are common and occasionally life-threatening","volume":"26","author":"Trelinska","year":"2015","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.spen.2015.10.003_bib38","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1212\/WNL.0b013e3182815428","article-title":"Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma","volume":"80","author":"Krueger","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2015.10.003_bib39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00381-010-1222-y","article-title":"Regression of subependymal giant cell astrocytomas with RAD001 (Everolimus) in tuberous sclerosis complex","volume":"27","author":"Yalon","year":"2011","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.spen.2015.10.003_bib40","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1177\/0883073813501870","article-title":"Subependymal giant cell astrocytomas in patients with tuberous sclerosis complex: consideration for surgical or pharmacotherapeutic intervention","volume":"29","author":"Wheless","year":"2014","journal-title":"J Child Neurol"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909115000704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909115000704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:37:26Z","timestamp":1761028646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909115000704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1071909115000704"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2015.10.003","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural History and Current Treatment Options for Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2015.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}